From April 1, 2022 to June 30, 2022, the company has repurchased 0 shares, representing 0% for CNY 0 million. With this, the company has completed the repurchase of 11,355,900 shares, representing 2.09% for CNY 174.83 million under the buyback announced on August 4, 2021.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
11.96 CNY | -2.21% | -2.69% | +27.78% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+27.78% | 892M | |
+35.01% | 709B | |
+30.96% | 595B | |
-2.60% | 367B | |
+20.83% | 334B | |
+5.69% | 289B | |
+14.42% | 239B | |
+9.41% | 211B | |
-4.29% | 203B | |
+10.77% | 171B |
- Stock Market
- Equities
- 300497 Stock
- News Jiangxi Fushine Pharmaceutical Co., Ltd.
- Tranche Update on Jiangxi Fushine Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on August 4, 2021.